BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$1.00−0.08 (-7.84%)
Close on Nov 17, 2026Market cap $7.51MP/E –Yield –
BioVie total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
BioVie's total debt was $2.97M at Sep 30, 2023. For fiscal 2023 it was $5.23M, down 56.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | $5.23M | -56.9% |
| FY2022 | Jun 30, 2022 | $12.14M | +19321.9% |
| FY2020 | Jun 30, 2020 | $62.50K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $2.97M | -76.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $5.23M | -56.9% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $7.41M | -36.3% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $13.26M | +19.3% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $12.73M | +20260.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $12.14M | +19321.9% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $11.62M | +18499.9% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $11.11M | +17677.9% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $62.50K | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $62.50K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $62.50K | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $62.50K | – |
See a number that looks wrong?